Improving systemic therapy for fumarate hydratase–deficient renal cell carcinoma Correspondence
| Author: | Carlo, M. I. |
| Title: | Improving systemic therapy for fumarate hydratase–deficient renal cell carcinoma |
| Keywords: | treatment outcome; treatment response; gene mutation; bevacizumab; erlotinib; sunitinib; cancer combination chemotherapy; drug efficacy; drug safety; monotherapy; systemic therapy; letter; cancer immunotherapy; progression free survival; pathology; renal cell carcinoma; kidney neoplasms; kidney tumor; carcinoma, renal cell; antiangiogenic therapy; uterus cancer; uterine neoplasms; merlin; scatter factor receptor; fumarate hydratase; phase 2 clinical trial (topic); overall response rate; first-line treatment; cabozantinib; nivolumab; humans; human; female; fumarate hydratase deficient renal cell carcinoma |
| Journal Title: | European Urology |
| Volume: | 83 |
| Issue: | 4 |
| ISSN: | 0302-2838 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2023-04-01 |
| Start Page: | e113 |
| End Page: | e114 |
| Language: | English |
| DOI: | 10.1016/j.eururo.2022.12.020 |
| PUBMED: | 36682904 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Letter -- Source: Scopus |
